Clinical Trial Update: Real World Effectiveness, Persistence, Tolerability, and Safety of Ofatumumab in Clinical Practice

View source ↗

Summary

Real-world study evaluating the effectiveness, persistence, tolerability, and safety of ofatumumab in multiple sclerosis patients treated in routine clinical pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Kesimpta (ofatumumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Sclerosis | Status: COMPLETED